Endobronchial ultrasound-guided transbronchial needle aspiration versus mediastinoscopy for mediastinal staging of lung cancer: A systematic review of economic evaluation studies.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 16 01 2020
accepted: 16 06 2020
entrez: 1 7 2020
pubmed: 1 7 2020
medline: 5 9 2020
Statut: epublish

Résumé

The emergence of endobronchial ultrasound (EBUS) changed the approach to staging lung cancer. As a new method being incorporated, the use of EBUS may lead to a shift in clinical and costs outcomes. The aim of this systematic review is to gather information to better understand the economic impact of implementing EBUS. This review is reported according to the PRISMA statement and registered on PROSPERO (CRD42019107901). Search keywords were elaborated considering descriptors of terms related to the disease (lung cancer / mediastinal staging of lung cancer) and the technologies of interest (EBUS and mediastinoscopy) combined with a specific economic filter. The literature search was performed in MEDLINE, EMBASE, LILACS, Cochrane Library of Trials, Web of Science, Scopus and National Health System Economic Evaluation Database (NHS EED) of the Center for Reviews and Dissemination (CRD). Screening, selection of articles, data extraction and quality assessment were carried out by two reviewers. Seven hundred and seventy publications were identified through the database searches. Eight articles were included in this review. All publications are full economic evaluation studies, one cost-effectiveness, three cost-utility, and four cost-minimization analyses. The costs of strategies using EBUS-TBNA were lower than the ones using mediastinoscopy in all studies analyzed. Two of the best quality scored studies demonstrate that the mediastinoscopy strategy is dominated by the EBUS-TBNA strategy. Information gathered in the eight studies of this systematic review suggest that EBUS is cost-effective compared to mediastinoscopy for mediastinal staging of lung cancer.

Identifiants

pubmed: 32603376
doi: 10.1371/journal.pone.0235479
pii: PONE-D-20-00791
pmc: PMC7326228
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0235479

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Health Econ. 2010 Mar;19(3):350-64
pubmed: 19378354
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Health Technol Assess. 2012;16(18):1-75, iii-iv
pubmed: 22472180
Cost Eff Resour Alloc. 2013 Mar 25;11(1):6
pubmed: 23531194
BMC Med Inform Decis Mak. 2016 Jan 26;16:9
pubmed: 26813400
Chest. 2013 May;143(5 Suppl):e211S-e250S
pubmed: 23649440
Ann Thorac Surg. 2016 Nov;102(5):1747-1755
pubmed: 27637288
Int J Technol Assess Health Care. 2010 Apr;26(2):170-4
pubmed: 20392320
Eur J Cardiothorac Surg. 2014 May;45(5):787-98
pubmed: 24578407
Expert Rev Pharmacoecon Outcomes Res. 2016 Dec;16(6):723-732
pubmed: 27762640
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Am J Respir Crit Care Med. 2014 Mar 15;189(6):640-9
pubmed: 24484269
J Thorac Oncol. 2010 Oct;5(10):1564-70
pubmed: 20871261
Value Health. 2019 Sep;22(9):1026-1032
pubmed: 31511179
Medicine (Baltimore). 2019 Sep;98(39):e17242
pubmed: 31574837
Thorax. 2011 Oct;66(10):889-93
pubmed: 21813622
Am J Respir Crit Care Med. 2012 Aug 1;186(3):255-60
pubmed: 22652031
J Thorac Cardiovasc Surg. 2017 Jun;153(6):1567-1578
pubmed: 28283236
Expert Rev Pharmacoecon Outcomes Res. 2016 Dec;16(6):705-721
pubmed: 27805466
Thorax. 2003 Dec;58(12):1083-6
pubmed: 14645981
Lung Cancer. 2010 Mar;67(3):366-71
pubmed: 19473723
Eur J Cancer. 2009 May;45(8):1389-96
pubmed: 19124238
Arch Bronconeumol. 2016 Feb;52(2):96-102
pubmed: 26565072
Eur Respir J. 2009 May;33(5):1156-64
pubmed: 19407050
Expert Rev Pharmacoecon Outcomes Res. 2016 Dec;16(6):689-704
pubmed: 27805469
BMJ. 2011 Apr 27;342:d2110
pubmed: 21525094
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
Thorax. 2009 Sep;64(9):757-62
pubmed: 19454408
Respiration. 2014;88(6):500-17
pubmed: 25377908
Value Health. 2013 Jan-Feb;16(1):57-65
pubmed: 23337216
Thorax. 2014 Jul;69(7):679-81
pubmed: 24064440
Respiration. 2014;87(1):3-8
pubmed: 24296947

Auteurs

João Pedro Steinhauser Motta (JP)

Instituto de Doenças do Torax, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Ricardo E Steffen (RE)

Instituto de Medicina Social, Universidade Estadual do Rio de Janeiro, Rio de Janeiro, Brazil.

Caroliny Samary Lobato (C)

Programa de Pós-Graduação em Clínica Médica da Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Vanessa Souza Mendonça (V)

Biblioteca do Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

José Roberto Lapa E Silva (JR)

Instituto de Doenças do Torax, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH